Jianhua Zhu Selected Research

Length of Stay

4/2024	Comprehensive assessment of risk factors and pathogenic characteristics of wound infections following thoracoscopic radical resection for lung cancer.
1/2020	Delayed-phase thrombocytopenia in patients with coronavirus disease 2019 (COVID-19).
1/2017	Effectiveness of enteral feeding protocol on clinical outcomes in critically ill patients: A before and after study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianhua Zhu Research Topics

Disease

44	Neoplasms (Cancer) 11/2023 - 08/2003
16	Breast Neoplasms (Breast Cancer) 11/2023 - 09/2003
12	Atherosclerosis 07/2018 - 12/2006
9	Hepatocellular Carcinoma (Hepatoma) 08/2023 - 02/2009
8	Inflammation (Inflammations) 01/2022 - 08/2011
8	Myocardial Infarction 01/2019 - 12/2009
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2014 - 12/2006
6	Type 2 Diabetes Mellitus (MODY) 01/2023 - 11/2018
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2009
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 11/2016
5	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 01/2019
5	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2014
5	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2014
5	Sepsis (Septicemia) 12/2021 - 12/2018
5	Acute Kidney Injury (Acute Renal Failure) 12/2021 - 12/2018
4	Infections 04/2023 - 02/2011
4	Dehydration (Water Stress) 11/2022 - 06/2004
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 03/2015
4	Thrombosis (Thrombus) 11/2017 - 01/2014
4	Carcinogenesis 11/2016 - 12/2004
4	Heart Failure 09/2015 - 01/2009
4	Brain Neoplasms (Brain Tumor) 06/2012 - 07/2011
3	Hemorrhage 03/2024 - 01/2017
3	Necrosis 09/2022 - 02/2011
3	Acute Coronary Syndrome 02/2020 - 01/2013
3	Thrombocytopenia (Thrombopenia) 01/2020 - 06/2012
3	Hypertension (High Blood Pressure) 01/2019 - 01/2009
3	Cardiomegaly (Heart Hypertrophy) 01/2017 - 12/2007
3	Glioma (Gliomas) 12/2015 - 09/2014
3	Glioblastoma (Glioblastoma Multiforme) 06/2012 - 08/2011
3	Hypertrophy 01/2011 - 12/2007
2	Lung Neoplasms (Lung Cancer) 04/2024 - 08/2003
2	Melanoma (Melanoma, Malignant) 12/2023 - 12/2022
2	Liver Neoplasms (Liver Cancer) 08/2023 - 12/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2016
2	Lymphoma (Lymphomas) 10/2022 - 01/2015
2	Ulcerative Colitis 01/2022 - 03/2015
2	Leukemia 11/2021 - 01/2015
2	Human Influenza (Influenza) 01/2021 - 12/2010
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020 - 01/2019
2	Diabetic Angiopathies (Diabetic Angiopathy) 01/2020 - 11/2018
2	Peripheral Arterial Disease 01/2020 - 01/2019
2	Adenocarcinoma of Lung 01/2019 - 07/2018
2	Insulin Resistance 01/2019 - 01/2019
2	Obesity 01/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2004
10	Peptides (Polypeptides)IBA 01/2022 - 01/2012
9	Biomarkers (Surrogate Marker)IBA 11/2023 - 06/2011
8	oxidized low density lipoproteinIBA 01/2022 - 12/2006
7	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 08/2011
6	Messenger RNA (mRNA)IBA 01/2022 - 09/2003
6	LigandsIBA 12/2015 - 12/2005
5	NAD (NADH)IBA 01/2023 - 01/2019
5	LipidsIBA 09/2022 - 12/2006
5	Long Noncoding RNAIBA 01/2022 - 01/2021
5	IntegrinsIBA 02/2021 - 01/2012
5	EnzymesIBA 01/2020 - 07/2005
4	AntioxidantsIBA 07/2023 - 08/2016
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2013
4	salicylhydroxamic acid (SHAM)IBA 12/2021 - 12/2018
4	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 02/2011
4	AcidsIBA 01/2020 - 01/2017
4	MicellesIBA 10/2018 - 06/2012
4	MicroRNAs (MicroRNA)IBA 02/2016 - 02/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 12/2019
3	RNA (Ribonucleic Acid)IBA 12/2022 - 02/2011
3	Monoclonal AntibodiesIBA 12/2021 - 08/2003
3	Adenosine Triphosphate (ATP)IBA 01/2020 - 01/2016
3	PolyethyleneimineIBA 06/2012 - 08/2011
3	poly(ethylene glycol)-co-poly(ethyleneimine)IBA 06/2012 - 08/2011
3	cyclic arginine-glycine-aspartic acid peptideIBA 06/2012 - 08/2011
3	Estrogen Receptor alphaIBA 02/2007 - 09/2003
3	Transcription Factors (Transcription Factor)IBA 02/2007 - 06/2004
2	Calcium-Binding ProteinsIBA 08/2023 - 09/2019
2	Glycoproteins (Glycoprotein)IBA 07/2023 - 02/2011
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2019
2	CateninsIBA 01/2023 - 06/2022
2	ElementsIBA 11/2022 - 06/2004
2	Amino Acids FDA Link 09/2022 - 03/2015
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022 - 01/2014
2	asparaginylendopeptidase (legumain)IBA 01/2022 - 01/2020
2	Vitamin D FDA LinkGeneric 01/2022 - 01/2020
2	Therapeutic UsesIBA 12/2021 - 08/2016
2	Caspase 3 (Caspase-3)IBA 12/2021 - 12/2018
2	Gemcitabine FDA Link 12/2021 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2014
2	AdipokinesIBA 01/2020 - 01/2019
2	ProdrugsIBA 01/2020 - 10/2018
2	NeuregulinsIBA 01/2020 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2019 - 09/2008
2	thiazolyl blueIBA 09/2019 - 12/2013

Therapy/Procedure

24	Therapeutics 08/2023 - 08/2003
9	Drug Therapy (Chemotherapy) 01/2023 - 05/2010
4	Stents 11/2017 - 01/2014
3	Length of Stay 04/2024 - 01/2017
3	Immunotherapy 01/2023 - 06/2021
3	Aftercare (After-Treatment) 09/2022 - 08/2003
2	Ligation 12/2021 - 07/2021